2. Academic Validation
  3. Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis

Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis

  • ACS Med Chem Lett. 2014 Jun 24;5(8):884-8. doi: 10.1021/ml500131a.
Yongzhen Li 1,  Tingting Feng 1,  Peng Liu 1,  Chang Liu 1,  Xiao Wang 1,  Dongsheng Li 1,  Ni Li 1,  Minghua Chen 1,  Yanni Xu 1,  Shuyi Si 1
Affiliations

Affiliation

  • 1 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College , Tiantanxili No. 1, Beijing 100050, China.
PMID: 25147608 DOI: 10.1021/ml500131a
Abstract

ATP-binding cassette transporter A1 (ABCA1) is a key transporter and receptor in promoting Cholesterol efflux, and increasing the expression level of ABCA1 is antiatherogenic. In our previous study, rutaecarpine (RUT) was found to protect apoE(-/-) mice from developing atherosclerosis through preferentially up-regulating ABCA1 expression. In the present work, a series of RUT derivatives were synthesized and examined as ABCA1 expression up-regulators. Compounds CD1, CD6, and BCD1-2 were found to possess the most potential activity as antiatherosclerotic agents among all compounds tested.

Keywords

ABCA1; RCT; Rutaecarpine; atherosclerosis.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z